Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
The 0.25 mg starting dose is intentionally sub-therapeutic for glycaemic control but serves as a tolerance-building phase
The ADA recommends A1c monitoring approximately every 3 months during treatment initiation and dose adjustments, with individualized glycemic targets
That habit pays off when you chase event milestones or balance multiple offers across a busy week
Users under 150 lbs may experience stronger side effects at standard doses, particularly with GLP-1 agonists
They were already destined to fall
Important safety information: Wegovy (semaglutide) and Mounjaro (tirzepatide) are prescription-only medications for managing obesity and, in the case of Mounjaro, also type 2 diabetes
